A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit. JAMA Neurol 2014;71:543-52. | USF Parkinson's Disease and Movement Disorders Center

Investigators, The Parkinson Study Group QE3. 2014. “A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit. JAMA Neurol 2014;71:543-52.”. JAMA Neurol.

Last updated on 10/03/2024